Tumor-induced Osteomalacia
📧 Sign up to get email alerts when something new happens for Tumor-induced Osteomalacia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: A Natural History Study of Bone and Mineral Disorders
A ClinicalTrials.gov listing indicates a natural history study of bone and mineral disorders is currently recruiting, focusing on tumor-indu…
-
CLINICAL_TRIALS research · 2026-01-26Clinical Trial Update: Al18F-NOTA-LM3 PET/CT in Patients With TIO [NA]
The clinical trial is recruiting to evaluate Al18F-NOTA-LM3 PET/CT imaging in patients with Tumor-Induced Osteomalacia.
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Tumor-induced Osteomalacia Disease Monitoring Program
This document describes an ongoing disease monitoring program for Tumor-induced Osteomalacia. The study is sponsored by Ultragenyx Pharmaceu…
-
CLINICAL_TRIALS trial_result · 2025-04-30Clinical Trial Update: Ga-DOTATATE PET for Phosphaturic Mesenchymal Tumors in Patients With Tumor Induced Osteomalacia [Phase 1, Phase 2]
This phase 1/2 trial evaluates gallium-68 DOTATATE PET imaging to localize phosphaturic mesenchymal tumors causing tumor-induced osteomalaci…
-
CLINICAL_TRIALS other · 2025-03-05Clinical Trial Update: Expanded Access to Burosumab
Expanded access program for burosumab is available for patients with X-linked Hypophosphatemia or Tumor-Induced Osteomalacia.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-07-09Clinical Trial Update: Study to Assess the Safety, Pharmacokinetics and Efficacy of KRN23 in Adult Chinese Patients With TIO [Phase 4]
Phase 4 clinical trial updating the safety, pharmacokinetics and efficacy of KRN23 in adult Chinese patients with tumor-induced osteomalacia…
-
CLINICAL_TRIALS trial_result · 2022-09-06Clinical Trial Update: A Study of KRN23 in Subjects With Tumor-Induced Osteomalacia or Epidermal Nevus Syndrome [Phase 2]
Phase 2 clinical trial update for KRN23 in subjects with tumor-induced osteomalacia or epidermal nevus syndrome has been completed.
-
CLINICAL_TRIALS trial_result · 2021-04-08Clinical Trial Update: BGJ398 for the Treatment of Tumor-Induced Osteomalacia [Phase 2]
Phase 2 trial of BGJ398 for tumor-induced osteomalacia was terminated; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2020-07-30Clinical Trial Update: Study of Burosumab (KRN23) in Adults With Tumor-Induced Osteomalacia (TIO) or Epidermal Nevus Syndrome (ENS) [Phase 2]
Phase 2 study of burosumab (KRN23) in adults with tumor-induced osteomalacia or epidermal nevus syndrome has completed, with results posted …
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Catheterization to Locate Mesenchymal Tumors in Patients With Tumor-Induced Osteomalacia or Oncogenic Osteomalacia
This record notes a completed clinical trial investigating catheter-based localization of mesenchymal tumors in patients with tumor-induced …
-
CLINICAL_TRIALS research · 2017-04-07Clinical Trial Update: 68Ga-DOTATATE PET/CT in Oncogenic Osteomalacia [EARLY_Phase 1]
Early-phase trial evaluating Ga-68 DOTATATE PET/CT to locate somatostatin receptor–expressing tumors causing oncogenic osteomalacia related …
-
CLINICAL_TRIALS research · 2016-07-06Clinical Trial Update: Observing the Changes of Fibroblast Growth Factor 23 in Patients of Tumor Induced Osteomalacia
An observational clinical trial from National Taiwan University Hospital tracks changes in fibroblast growth factor 23 (FGF23) levels in pat…
-
CLINICAL_TRIALS research · 2015-01-06Clinical Trial Update: Molecular Pathways Involved in the Pathogenesis and Behavior of Mesenchymal Phosphaturic Tumors Causing Oncogenic Osteomalacia
Clinical trial update examining molecular pathways involved in mesenchymal phosphaturic tumors that cause tumor-induced osteomalacia.